This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Song, L.-N.
Right arrow Articles by Gelmann, E. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Song, L.-N.
Right arrow Articles by Gelmann, E. P.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, March 2003, p. 1674-1687, Vol. 23, No. 5
0270-7306/03/$08.00+0     DOI: 10.1128/MCB.23.5.1674-1687.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

ß-Catenin Binds to the Activation Function 2 Region of the Androgen Receptor and Modulates the Effects of the N-Terminal Domain and TIF2 on Ligand-Dependent Transcription

Liang-Nian Song,1 Roger Herrell,1 Stephen Byers,1 Salimuddin Shah,1 Elizabeth M. Wilson,2 and Edward P. Gelmann1*

Department of Oncology, Lombardi Cancer Center, Georgetown University School of Medicine, Washington, D.C. 20007-2197,1 Laboratory for Reproductive Biology, University of North Carolina, Chapel Hill, North Carolina 275992

Received 8 May 2002/ Returned for modification 30 July 2002/ Accepted 3 December 2002

ß-Catenin is a multifunctional molecule that is activated by signaling through WNT receptors. ß-Catenin can also enhance the transcriptional activity of some steroid hormone receptors such as the androgen receptor and retinoic acid receptor {alpha}. Androgens can affect nuclear translocation of ß-catenin and influence its subcellular distribution. Using mammalian two-hybrid binding assays, analysis of reporter gene transcription, and coimmunoprecipitation, we now show that ß-catenin binds to the androgen receptor ligand-binding domain (LBD) and modulates the transcriptional effects of TIF2 and the androgen receptor N-terminal domain (NTD). In functional assays, ß-catenin bound to androgen receptor only in the presence of ligand agonists, not antagonists. ß-Catenin binding to the androgen receptor LBD was independent of and cooperative with the androgen receptor NTD and the p160 coactivator TIF2, both of which bind to the activation function 2 (AF-2) region of the androgen receptor. Different mutations of androgen receptor helix 3 amino acids disrupted binding of androgen receptor NTD and ß-catenin. ß-Catenin, androgen receptor NTD, and TIF2 binding to the androgen receptor LBD were affected similarly by a subset of helix 12 mutations, but disruption of two sites on helix 12 affected only binding of ß-catenin and not of TIF2 or the androgen receptor NTD. Mutational disruption of each of five LXXLL peptide motifs in the ß-catenin armadillo repeats did not disrupt either binding to androgen receptor or transcriptional coactivation. ICAT, an inhibitor of T-cell factor 4 (TCF-4), and E-cadherin binding to ß-catenin also blocked binding of the androgen receptor LBD. We also demonstrated cross talk between the WNT and androgen receptor signaling pathways because excess androgen receptor could interfere with WNT signaling and excess TCF-4 inhibited the interaction of ß-catenin and androgen receptor. Taken together, the data show that ß-catenin can bind to the androgen receptor LBD and modulate the effects of the androgen receptor NTD and TIF2 on transcription.


* Corresponding author. Mailing address: Department of Oncology, Lombardi Cancer Center, Georgetown University School of Medicine, 3800 Reservoir Rd. NW, Washington, DC 20007-2197. Phone: (202) 687-2207. Fax: (202) 784-1229. E-mail: gelmanne{at}georgetown.edu.


Molecular and Cellular Biology, March 2003, p. 1674-1687, Vol. 23, No. 5
0022-538X/03/$08.00+0     DOI: 10.1128/MCB.23.5.1674-1687.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Ou, C.-Y., Kim, J. H., Yang, C. K., Stallcup, M. R. (2009). Requirement of Cell Cycle and Apoptosis Regulator 1 for Target Gene Activation by Wnt and {beta}-Catenin and for Anchorage-independent Growth of Human Colon Carcinoma Cells. J. Biol. Chem. 284: 20629-20637 [Abstract] [Full Text]  
  • Hernandez Gifford, J. A., Hunzicker-Dunn, M. E., Nilson, J. H. (2009). Conditional Deletion of Beta-Catenin Mediated by Amhr2cre in Mice Causes Female Infertility. Biol. Reprod. 80: 1282-1292 [Abstract] [Full Text]  
  • Wang, G., Wang, J., Sadar, M. D. (2008). Crosstalk between the Androgen Receptor and {beta}-Catenin in Castrate-Resistant Prostate Cancer. Cancer Res. 68: 9918-9927 [Abstract] [Full Text]  
  • Song, L.-N., Gelmann, E. P. (2008). Silencing Mediator for Retinoid and Thyroid Hormone Receptor and Nuclear Receptor Corepressor Attenuate Transcriptional Activation by the {beta}-Catenin-TCF4 Complex. J. Biol. Chem. 283: 25988-25999 [Abstract] [Full Text]  
  • Salisbury, T. B., Binder, A. K., Nilson, J. H. (2008). Welcoming {beta}-Catenin to the Gonadotropin-Releasing Hormone Transcriptional Network in Gonadotropes. Mol. Endocrinol. 22: 1295-1303 [Abstract] [Full Text]  
  • Handeli, S., Simon, J. A. (2008). A small-molecule inhibitor of Tcf/{beta}-catenin signaling down-regulates PPAR{gamma} and PPAR{delta} activities. Molecular Cancer Therapeutics 7: 521-529 [Abstract] [Full Text]  
  • Heemers, H. V., Tindall, D. J. (2007). Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex. Endocr. Rev. 28: 778-808 [Abstract] [Full Text]  
  • Read, J. T., Rahmani, M., Boroomand, S., Allahverdian, S., McManus, B. M., Rennie, P. S. (2007). Androgen Receptor Regulation of the Versican Gene through an Androgen Response Element in the Proximal Promoter. J. Biol. Chem. 282: 31954-31963 [Abstract] [Full Text]  
  • Cianferotti, L., Cox, M., Skorija, K., Demay, M. B. (2007). Vitamin D receptor is essential for normal keratinocyte stem cell function. Proc. Natl. Acad. Sci. USA 104: 9428-9433 [Abstract] [Full Text]  
  • Kang, S., Bennett, C. N., Gerin, I., Rapp, L. A., Hankenson, K. D., MacDougald, O. A. (2007). Wnt Signaling Stimulates Osteoblastogenesis of Mesenchymal Precursors by Suppressing CCAAT/Enhancer-binding Protein {alpha} and Peroxisome Proliferator-activated Receptor {gamma}. J. Biol. Chem. 282: 14515-14524 [Abstract] [Full Text]  
  • Salisbury, T. B., Binder, A. K., Grammer, J. C., Nilson, J. H. (2007). Maximal Activity of the Luteinizing Hormone{beta}-Subunit Gene Requires {beta}-Catenin. Mol. Endocrinol. 21: 963-971 [Abstract] [Full Text]  
  • Chen, Y.-H., Yang, C. K., Xia, M., Ou, C.-Y., Stallcup, M. R. (2007). Role of GAC63 in transcriptional activation mediated by {beta}-catenin. Nucleic Acids Res 35: 2084-2092 [Abstract] [Full Text]  
  • Schepsky, A., Bruser, K., Gunnarsson, G. J., Goodall, J., Hallsson, J. H., Goding, C. R., Steingrimsson, E., Hecht, A. (2006). The Microphthalmia-Associated Transcription Factor Mitf Interacts with {beta}-Catenin To Determine Target Gene Expression. Mol. Cell. Biol. 26: 8914-8927 [Abstract] [Full Text]  
  • Yang, C. K., Kim, J. H., Stallcup, M. R. (2006). Role of the N-Terminal Activation Domain of the Coiled-Coil Coactivator in Mediating Transcriptional Activation by {beta}-Catenin. Mol. Endocrinol. 20: 3251-3262 [Abstract] [Full Text]  
  • Lee, Y.-H., Stallcup, M. R. (2006). Interplay of Fli-I and FLAP1 for regulation of {beta}-catenin dependent transcription. Nucleic Acids Res 0: gkl652v3-8 [Abstract] [Full Text]  
  • Takayama, S., Rogatsky, I., Schwarcz, L. E., Darimont, B. D. (2006). The Glucocorticoid Receptor Represses Cyclin D1 by Targeting the Tcf-beta-Catenin Complex. J. Biol. Chem. 281: 17856-17863 [Abstract] [Full Text]  
  • Yang, C. K., Kim, J. H., Li, H., Stallcup, M. R. (2006). Differential Use of Functional Domains by Coiled-coil Coactivator in Its Synergistic Coactivator Function with beta-Catenin or GRIP1. J. Biol. Chem. 281: 3389-3397 [Abstract] [Full Text]  
  • Chen, S.-Y., Wulf, G., Zhou, X. Z., Rubin, M. A., Lu, K. P., Balk, S. P. (2006). Activation of {beta}-Catenin Signaling in Prostate Cancer by Peptidyl-Prolyl Isomerase Pin1-Mediated Abrogation of the Androgen Receptor-{beta}-Catenin Interaction. Mol. Cell. Biol. 26: 929-939 [Abstract] [Full Text]  
  • Ghogomu, S. M., van Venrooy, S., Ritthaler, M., Wedlich, D., Gradl, D. (2006). HIC-5 Is a Novel Repressor of Lymphoid Enhancer Factor/T-cell Factor-driven Transcription. J. Biol. Chem. 281: 1755-1764 [Abstract] [Full Text]  
  • Mulholland, D. J., Dedhar, S., Coetzee, G. A., Nelson, C. C. (2005). Interaction of Nuclear Receptors with the Wnt/{beta}-Catenin/Tcf Signaling Axis: Wnt You Like to Know?. Endocr. Rev. 26: 898-915 [Abstract] [Full Text]  
  • Song, L.-N., Gelmann, E. P. (2005). Interaction of {beta}-Catenin and TIF2/GRIP1 in Transcriptional Activation by the Androgen Receptor. J. Biol. Chem. 280: 37853-37867 [Abstract] [Full Text]  
  • Stojadinovic, O., Brem, H., Vouthounis, C., Lee, B., Fallon, J., Stallcup, M., Merchant, A., Galiano, R. D., Tomic-Canic, M. (2005). Molecular Pathogenesis of Chronic Wounds: The Role of {beta}-Catenin and c-myc in the Inhibition of Epithelialization and Wound Healing. Am. J. Pathol. 167: 59-69 [Abstract] [Full Text]  
  • Jung, C., Kim, R.-S., Zhang, H.-J., Lee, S.-J., Jeng, M.-H. (2004). HOXB13 Induces Growth Suppression of Prostate Cancer Cells as a Repressor of Hormone-Activated Androgen Receptor Signaling. Cancer Res. 64: 9185-9192 [Abstract] [Full Text]  
  • Li, Q., Dashwood, R. H. (2004). Activator Protein 2{alpha} Associates with Adenomatous Polyposis Coli/{beta}-Catenin and Inhibits {beta}-Catenin/T-cell Factor Transcriptional Activity in Colorectal Cancer Cells. J. Biol. Chem. 279: 45669-45675 [Abstract] [Full Text]  
  • Liu, J., Farmer, S. R. (2004). Regulating the Balance between Peroxisome Proliferator-activated Receptor {gamma} and {beta}-Catenin Signaling during Adipogenesis: A GLYCOGEN SYNTHASE KINASE 3{beta} PHOSPHORYLATION-DEFECTIVE MUTANT OF {beta}-CATENIN INHIBITS EXPRESSION OF A SUBSET OF ADIPOGENIC GENES. J. Biol. Chem. 279: 45020-45027 [Abstract] [Full Text]  
  • Masiello, D., Chen, S.-Y., Xu, Y., Verhoeven, M. C., Choi, E., Hollenberg, A. N., Balk, S. P. (2004). Recruitment of {beta}-Catenin by Wild-Type or Mutant Androgen Receptors Correlates with Ligand-Stimulated Growth of Prostate Cancer Cells. Mol. Endocrinol. 18: 2388-2401 [Abstract] [Full Text]  
  • Sharma, C., Pradeep, A., Wong, L., Rana, A., Rana, B. (2004). Peroxisome Proliferator-activated Receptor {gamma} Activation Can Regulate {beta}-Catenin Levels via a Proteasome-mediated and Adenomatous Polyposis Coli-independent Pathway. J. Biol. Chem. 279: 35583-35594 [Abstract] [Full Text]  
  • Liao, X., Thrasher, J. B., Holzbeierlein, J., Stanley, S., Li, B. (2004). Glycogen Synthase Kinase-3{beta} Activity Is Required for Androgen-Stimulated Gene Expression in Prostate Cancer. Endocrinology 145: 2941-2949 [Abstract] [Full Text]  
  • Chesire, D. R., Dunn, T. A., Ewing, C. M., Luo, J., Isaacs, W. B. (2004). Identification of Aryl Hydrocarbon Receptor as a Putative Wnt/{beta}-Catenin Pathway Target Gene in Prostate Cancer Cells. Cancer Res. 64: 2523-2533 [Abstract] [Full Text]  
  • Li, H., Kim, J. H., Koh, S. S., Stallcup, M. R. (2004). Synergistic Effects of Coactivators GRIP1 and {beta}-Catenin on Gene Activation: CROSS-TALK BETWEEN ANDROGEN RECEPTOR AND Wnt SIGNALING PATHWAYS. J. Biol. Chem. 279: 4212-4220 [Abstract] [Full Text]  
  • Song, L.-N., Coghlan, M., Gelmann, E. P. (2004). Antiandrogen Effects of Mifepristone on Coactivator and Corepressor Interactions with the Androgen Receptor. Mol. Endocrinol. 18: 70-85 [Abstract] [Full Text]  
  • Shah, S., Hecht, A., Pestell, R., Byers, S. W. (2003). Trans-repression of {beta}-Catenin Activity by Nuclear Receptors. J. Biol. Chem. 278: 48137-48145 [Abstract] [Full Text]  
  • Jordan, B. K., Shen, J. H.-C., Olaso, R., Ingraham, H. A., Vilain, E. (2003). Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/{beta}-catenin synergy. Proc. Natl. Acad. Sci. USA 100: 10866-10871 [Abstract] [Full Text]  
  • Amir, A. L., Barua, M., McKnight, N. C., Cheng, S., Yuan, X., Balk, S. P. (2003). A Direct {beta}-Catenin-independent Interaction between Androgen Receptor and T Cell Factor 4. J. Biol. Chem. 278: 30828-30834 [Abstract] [Full Text]